Makrofagno stimulišući proteinski receptor je protein koji je kod ljudi kodiran MST1Rgenom.[1][2] MST1R je takođe poznat kao RON (Recepteur d'Origine Nantais) kinaza, pri čemu ime potiče od francuskog grada u kome je otkriven. On je srodan sa c-MET receptorskom tirozinsko kinazom.[1][3]
↑Li BQ, Wang MH, Kung HF, Ronsin C, Breathnach R, Leonard EJ, Kamata T (November 1995). „Macrophage-stimulating protein activates Ras by both activation and translocation of SOS nucleotide exchange factor”. Biochem. Biophys. Res. Commun.216 (1): 110–8. DOI:10.1006/bbrc.1995.2598. PMID7488076.
Li BQ, Wang MH, Kung HF, et al. (1995). „Macrophage-stimulating protein activates Ras by both activation and translocation of SOS nucleotide exchange factor”. Biochem. Biophys. Res. Commun.216 (1): 110–8. DOI:10.1006/bbrc.1995.2598. PMID7488076.
Wang MH, Ronsin C, Gesnel MC, et al. (1994). „Identification of the ron gene product as the receptor for the human macrophage stimulating protein”. Science266 (5182): 117–9. DOI:10.1126/science.7939629. PMID7939629.
Follenzi A, Bakovic S, Gual P, et al. (2000). „Cross-talk between the proto-oncogenes Met and Ron”. Oncogene19 (27): 3041–9. DOI:10.1038/sj.onc.1203620. PMID10871856.
Chen YQ, Zhou YQ, Fisher JH, Wang MH (2002). „Targeted expression of the receptor tyrosine kinase RON in distal lung epithelial cells results in multiple tumor formation: oncogenic potential of RON in vivo”. Oncogene21 (41): 6382–6. DOI:10.1038/sj.onc.1205783. PMID12214279.
Zhou YQ, He C, Chen YQ, et al. (2003). „Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potential”. Oncogene22 (2): 186–97. DOI:10.1038/sj.onc.1206075. PMID12527888.
Penengo L, Rubin C, Yarden Y, Gaudino G (2003). „c-Cbl is a critical modulator of the Ron tyrosine kinase receptor”. Oncogene22 (24): 3669–79. DOI:10.1038/sj.onc.1206585. PMID12802274.
Maggiora P, Lorenzato A, Fracchioli S, et al. (2003). „The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasiveness”. Exp. Cell Res.288 (2): 382–9. DOI:10.1016/S0014-4827(03)00250-7. PMID12915129.
Santoro MM, Gaudino G, Marchisio PC (2003). „The MSP receptor regulates alpha6beta4 and alpha3beta1 integrins via 14-3-3 proteins in keratinocyte migration”. Dev. Cell5 (2): 257–71. DOI:10.1016/S1534-5807(03)00201-6. PMID12919677.
Angeloni D, Danilkovitch-Miagkova A, Miagkov A, et al. (2004). „The soluble sema domain of the RON receptor inhibits macrophage-stimulating protein-induced receptor activation”. J. Biol. Chem.279 (5): 3726–32. DOI:10.1074/jbc.M309342200. PMID14597639.
van den Akker E, van Dijk T, Parren-van Amelsvoort M, et al. (2004). „Tyrosine kinase receptor RON functions downstream of the erythropoietin receptor to induce expansion of erythroid progenitors”. Blood103 (12): 4457–65. DOI:10.1182/blood-2003-08-2713. PMID14982882.
Raeppel S, Gaudette G, et al. (2010). „Identification of a novel series of potent RON receptor tyrosine kinase inhibitors”. Bioorg. Med. Chem. Lett.20 (9): 2745–9. DOI:10.1016/j.bmcl.2010.03.073.